JP2023513749A5 - - Google Patents

Info

Publication number
JP2023513749A5
JP2023513749A5 JP2022548910A JP2022548910A JP2023513749A5 JP 2023513749 A5 JP2023513749 A5 JP 2023513749A5 JP 2022548910 A JP2022548910 A JP 2022548910A JP 2022548910 A JP2022548910 A JP 2022548910A JP 2023513749 A5 JP2023513749 A5 JP 2023513749A5
Authority
JP
Japan
Prior art keywords
promoter
identity
seq
mybpc3
raav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022548910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513749A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017699 external-priority patent/WO2021163357A2/en
Publication of JP2023513749A publication Critical patent/JP2023513749A/ja
Publication of JP2023513749A5 publication Critical patent/JP2023513749A5/ja
Pending legal-status Critical Current

Links

JP2022548910A 2020-02-13 2021-02-11 心疾患を治療するための遺伝子療法ベクター Pending JP2023513749A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062976160P 2020-02-13 2020-02-13
US62/976,160 2020-02-13
US202063047633P 2020-07-02 2020-07-02
US63/047,633 2020-07-02
PCT/US2021/017699 WO2021163357A2 (en) 2020-02-13 2021-02-11 Gene therapy vectors for treating heart disease

Publications (2)

Publication Number Publication Date
JP2023513749A JP2023513749A (ja) 2023-04-03
JP2023513749A5 true JP2023513749A5 (https=) 2024-02-15

Family

ID=77273691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548910A Pending JP2023513749A (ja) 2020-02-13 2021-02-11 心疾患を治療するための遺伝子療法ベクター

Country Status (12)

Country Link
US (5) US11129908B2 (https=)
EP (1) EP4103214B1 (https=)
JP (1) JP2023513749A (https=)
KR (1) KR20220139956A (https=)
CN (1) CN116096394A (https=)
AU (1) AU2021218411A1 (https=)
BR (1) BR112022015979A2 (https=)
CA (1) CA3171166A1 (https=)
CO (1) CO2022012917A2 (https=)
IL (1) IL295529A (https=)
MX (1) MX2022009883A (https=)
MY (1) MY209860A (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4103214B1 (en) 2020-02-13 2026-04-29 Tenaya Therapeutics, Inc. Gene therapy vectors for treating heart disease
US12552838B2 (en) 2020-04-20 2026-02-17 Tenaya Therapeutics, Inc. Adeno-associated virus with engineered capsid
BR112023006305A2 (pt) 2020-10-09 2023-05-09 Tenaya Therapeutics Inc Métodos e composições de terapia gênica com placofilina-2
IL313426A (en) * 2021-12-10 2024-08-01 Aavantibio Inc Methods and preparations for treating MYBPC3-associated hypertrophic cardiomyopathy with a viral vector
WO2023201207A1 (en) 2022-04-11 2023-10-19 Tenaya Therapeutics, Inc. Adeno-associated virus with engineered capsid
WO2024054864A1 (en) 2022-09-06 2024-03-14 Tenaya Therapeutics, Inc. Cardioprotective heart disease therapies
CN120380156A (zh) 2022-09-22 2025-07-25 迪纳柯公司 用aav基因治疗载体治疗心肌病
TW202421788A (zh) 2022-09-22 2024-06-01 美商拜奧馬林製藥公司 用aav基因療法載體治療致心律不整性心肌病
WO2024163571A1 (en) * 2023-02-01 2024-08-08 Board Of Regents, The University Of Texas System MESSENGER RNA ENGINEERED THERAPEUTICS FOR TREATING GENETIC DISORDERS (MeET)
WO2024215655A1 (en) 2023-04-10 2024-10-17 Tenaya Therapeutics, Inc. Cardioprotective bag3 therapies
WO2024215653A1 (en) 2023-04-10 2024-10-17 Tenaya Therapeutics, Inc. Guide rnas, vectors, and virions for targeting mutations in the pln gene
EP4719493A2 (en) * 2023-05-31 2026-04-08 Ohio State Innovation Foundation Cpt1 gene therapy and methods for treating or preventing cardiovascular diseases
TW202525313A (zh) 2023-09-06 2025-07-01 瑞士商迪納柯公司 用aav基因治療載體及治療調配物治療肥厚性心肌病之方法
WO2025083591A2 (en) * 2023-10-17 2025-04-24 Regel Therapeutics, Inc. Genetic regulatory elements for cardiac tissue expression and uses thereof
WO2025162449A1 (en) * 2024-01-30 2025-08-07 Inspirar Limited Compositions and methods for the treatment of heart disease
WO2025238182A1 (en) * 2024-05-15 2025-11-20 Stichting Amsterdam UMC Optimized aav-mediated transduction of cardiomyocytes
CN118879713B (zh) * 2024-07-17 2025-09-26 天津医科大学 一种人工设计的新型nrg-1在疾病治疗中的应用

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266488A (en) 1988-04-06 1993-11-30 The Regents Of The University Of California Troponin T gene promoter and derivatives thereof
WO2001029062A2 (en) 1999-10-18 2001-04-26 University Technology Corporation Method for modulation of cell phenotype
WO2002081632A2 (en) 2001-04-04 2002-10-17 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Nucleic acids for transgene expression
CN1880457B (zh) * 2001-10-11 2010-05-26 麦克公司 Ad6重组核酸
US20030221207A1 (en) 2002-02-13 2003-11-27 Pharmacia Corporation, Global Patent Department Cardiac-specific 11beta hydroxysteroid dehydrogenase type 2 transgenic mice
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
CN101056539B (zh) 2004-09-09 2012-12-12 综合医院公司 调节心脏细胞中的磷酸酶活性
JP5136766B2 (ja) 2004-12-15 2013-02-06 ユニバーシティ オブ ノース カロライナ アット チャペル ヒル キメラベクター
US9018440B2 (en) 2006-10-27 2015-04-28 Stowers Institute For Medical Research Fluorescent mouse model
US20100261169A1 (en) 2007-01-29 2010-10-14 Shira Wallach Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
ES2714007T3 (es) 2007-04-09 2019-05-24 Univ Florida Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso
US9725485B2 (en) 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
US20090133138A1 (en) * 2007-11-15 2009-05-21 Huai-Jen Tsai New gene fragment, novel transgenic zebrafish and methods for producing transgenic zebrafish
WO2009065080A1 (en) 2007-11-16 2009-05-22 San Diego State University Research Foundation Compositions and method for manipulating pim-1 activity in circulatory system cells
WO2009137006A2 (en) 2008-04-30 2009-11-12 The University Of North Carolina At Chapel Hill Directed evolution and in vivo panning of virus vectors
US9217155B2 (en) 2008-05-28 2015-12-22 University Of Massachusetts Isolation of novel AAV'S and uses thereof
US20110158947A1 (en) 2008-07-11 2011-06-30 Aleksandar Jovanovic Sulfonylurea receptor and means for treating ischaemia
US20110165680A1 (en) 2008-09-12 2011-07-07 Scarab Genomics, Llc Clean genome bactofection
WO2010093784A2 (en) 2009-02-11 2010-08-19 The University Of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
CN103608455B (zh) * 2011-01-07 2019-01-15 应用遗传科技公司 用于治疗色盲和其它疾病的启动子、表达盒、载体、药盒和方法
DE102011018586A1 (de) 2011-04-26 2012-10-31 Oliver Müller Vektorsystem zur spezifischen Genexpression im Herzmuskel
EP2714709B1 (en) 2011-05-26 2018-04-18 University of Washington Compositions for use in cell and gene based methods to improve cardiac function
JP2014520551A (ja) 2011-07-11 2014-08-25 セルラー ダイナミクス インターナショナル, インコーポレイテッド 細胞のリプログラミング方法およびゲノムの改変方法
CN111500665A (zh) 2011-07-21 2020-08-07 小利兰·斯坦福大学托管委员会 来自患者的诱导性多能干细胞的心肌细胞及其使用方法
US8933048B2 (en) 2011-09-21 2015-01-13 Case Western Reserve University Methods of treating cardiomyopathy
US20130136729A1 (en) 2011-11-11 2013-05-30 University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors
US9051387B2 (en) 2012-06-22 2015-06-09 Wisconsin Alumni Research Foundation Inhibition of MyBP-C binding to myosin as a treatment for heart failure
US9845465B2 (en) * 2012-08-15 2017-12-19 University Of Virginia Patent Foundation Compositions and methods for treating peripheral arterial disease
EP2792742A1 (en) 2013-04-17 2014-10-22 Universitätsklinikum Hamburg-Eppendorf (UKE) Gene-therapy vectors for treating cardiomyopathy
US20160237430A1 (en) 2013-09-23 2016-08-18 President And Fellows Of Harvard College Allele-specific rna silencing for the treatment of hypertrophic cardiomyopathy
JP6707028B2 (ja) 2013-12-09 2020-06-10 ベイラー カレッジ オブ メディスンBaylor College Of Medicine 心筋細胞新生におけるhippo及びジストロフィン複合体シグナル伝達
DE102014000857A1 (de) 2014-01-27 2015-07-30 Martin-Luther-Universität Halle-Wittenberg Hybridom-Zelllinie (My-C-cC0C2-235-3H8) und deren Verwendung zur Herstellung eines monoklonalen Antikörpers gegen das humane, herzspezifische Myosin Binding Protein C (C-protein, MYBPC3, cMyBP-C oder My-C)
US10072251B2 (en) 2014-02-19 2018-09-11 University Of Massachusetts Recombinant AAVS having useful transcytosis properties
WO2015124546A1 (en) 2014-02-19 2015-08-27 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii- Cnic Aav vectors for the treatment of ischemic and non-ischemic heart disease
WO2015153357A1 (en) 2014-03-29 2015-10-08 Beat Biotherapeutics Corp. Compositions and methods for improving cardiac function
US9611304B2 (en) 2014-05-29 2017-04-04 The University Of British Columbia TNNT1 mini-promoters
US10370432B2 (en) 2014-10-03 2019-08-06 University Of Massachusetts Heterologous targeting peptide grafted AAVS
CN107073051B (zh) 2014-10-21 2021-08-24 马萨诸塞大学 重组aav变体及其用途
JP6832280B2 (ja) 2015-01-16 2021-02-24 ユニバーシティ オブ ワシントンUniversity of Washington 新規のマイクロジストロフィンおよび使用の関連する方法
JP6836999B2 (ja) 2015-03-24 2021-03-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California アデノ随伴ウイルス変異体及びその使用方法
EP3283126B1 (en) 2015-04-16 2019-11-06 Emory University Recombinant promoters and vectors for protein expression in liver and use thereof
WO2017091807A1 (en) 2015-11-25 2017-06-01 University Of Miami Peptide inhibitors for calcineurin
KR102423442B1 (ko) 2015-12-11 2022-07-20 캘리포니아 인스티튜트 오브 테크놀로지 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
JP7406783B2 (ja) 2015-12-14 2023-12-28 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質
MX2018007330A (es) * 2015-12-15 2019-03-14 Genzyme Corp Vectores virales adeno-asociados para tratar mucolipidosis de tipo ii.
US11866462B2 (en) 2016-05-04 2024-01-09 Oregon Health & Science University Recombinant adeno-associated viral vectors
WO2017212019A1 (en) 2016-06-09 2017-12-14 Centre National De La Recherche Scientifique (Cnrs) Raav with chemically modified capsid
WO2018050783A1 (en) 2016-09-14 2018-03-22 Ruprecht-Karls-Universität Adeno-associated virus (aav) based regulatory system
WO2018067701A2 (en) 2016-10-05 2018-04-12 The Regents Of The University Of California Cardiac tissue models and methods of use thereof
CN108384806A (zh) 2016-10-17 2018-08-10 新疆医科大学第附属医院 hPDGF-BB与hFGF2双基因重组病毒载体及其应用
EP3534930A1 (en) 2016-11-04 2019-09-11 Ruprecht-Karls-Universität Heidelberg Wnt antagonists and their use in methods for treating myocardial infarction
JOP20190166A1 (ar) * 2017-01-05 2019-07-02 Univ Texas استراتيجية مثلى من أجل تعديلات تخطي إكسون باستخدام crispr/cas9 مع متواليات توجيه ثلاثي
US11905312B2 (en) 2017-02-15 2024-02-20 The University Of North Carolina At Chapel Hill Methods and compositions for gene transfer across the vasculature
US10550405B2 (en) 2017-03-15 2020-02-04 The University Of North Carolina At Chapel Hill Rational polyploid adeno-associated virus vectors and methods of making and using the same
WO2018222503A1 (en) 2017-05-31 2018-12-06 The Regents Of The University Of California Adeno-associated virus with variant capsid and methods of use thereof
EP3658157B1 (en) 2017-07-06 2023-07-26 Michael S. Kapiloff Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap)
EP3808849A1 (en) 2017-08-03 2021-04-21 Voyager Therapeutics, Inc. Compositions and methods for delivery of aav
ES2976559T3 (es) 2017-09-20 2024-08-05 Univ California Terapia génica con conexina 43 para restaurar la función eléctrica y cardíaca y la estructura cardíaca, en la miocardiopatía arritmogénica del ventrículo derecho
RU2770922C2 (ru) 2017-09-20 2022-04-25 4Д Молекьюлар Терапьютикс Инк. Капсиды вариантов аденоассоциированных вирусов и методы их применения
CN111886029B (zh) 2018-01-19 2024-04-12 新加坡科技研究局 破坏linc复合物以治疗核纤层蛋白病
GB2571704A (en) 2018-02-22 2019-09-11 Georg August Univ Gottingen Stiftung Offentlichen Rechts Univer Sitatsmedzin Goettingen Prevention or treatment of cardiac arrhytmia and sudden cardiac death
CN112153990A (zh) * 2018-03-23 2020-12-29 纽约市哥伦比亚大学理事会 用于常染色体显性疾病的基因编辑
WO2020014471A1 (en) 2018-07-11 2020-01-16 The Brigham And Women's Hospital, Inc. Methods and compositions for delivery of agents across the blood-brain barrier
US11242368B2 (en) 2018-09-21 2022-02-08 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and compositions for rapidly replacing cardiac myosin binding protein-C in sarcomeres
KR20220022107A (ko) 2018-12-05 2022-02-24 아베오나 테라퓨틱스 인코퍼레이티드 유전자 전달을 위한 재조합 아데노-연관 바이러스 벡터
CN109810981A (zh) 2019-02-19 2019-05-28 上海交通大学医学院附属第九人民医院 多聚核苷酸及其在心血管疾病诊断和治疗中的应用
AR118465A1 (es) 2019-03-21 2021-10-06 Stridebio Inc Vectores de virus adenoasociados recombinantes
KR102934700B1 (ko) 2019-03-28 2026-03-09 더 제너럴 하스피탈 코포레이션 트랜스진 발현을 위한 조작된 아데노-연관 (aav) 벡터
US20200405824A1 (en) 2019-06-26 2020-12-31 University Of Washington Use of ribonucleotide reductase alone or in combination with micro-dystrophin to treat duchenne muscular dystrophy striated muscle disease
EP4021527B1 (en) 2019-08-27 2024-03-06 Dinaqor AG Drug perfusion into an unarrested beating heart
TWI897882B (zh) 2019-09-20 2025-09-21 英商Ucl商業有限責任公司 右心室心律失常性心肌病之基因療法組合物及治療
EP4073257A1 (en) 2019-12-09 2022-10-19 UCL Business Ltd Gene therapy composition and treatment for myh7-linked cardiomyopathy
EP4081643A1 (en) 2019-12-24 2022-11-02 Asklepios Biopharmaceutical, Inc. Regulatory nucleic acid sequences
EP4103214B1 (en) 2020-02-13 2026-04-29 Tenaya Therapeutics, Inc. Gene therapy vectors for treating heart disease
WO2021163357A2 (en) 2020-02-13 2021-08-19 Tenaya Therapeutics, Inc. Gene therapy vectors for treating heart disease
US12552838B2 (en) 2020-04-20 2026-02-17 Tenaya Therapeutics, Inc. Adeno-associated virus with engineered capsid
CA3186584A1 (en) 2020-07-08 2022-01-13 Children's Medical Center Corporation Mybpc3 polypeptides and uses thereof
KR20230042468A (ko) 2020-08-05 2023-03-28 스페이스크래프트 세븐, 엘엘씨 Csrp3 (시스테인 및 글리신 풍부 단백질 3) 유전자 요법
KR20230043869A (ko) 2020-08-07 2023-03-31 스페이스크래프트 세븐, 엘엘씨 Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
JP2024501821A (ja) 2020-12-23 2024-01-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 心臓組織細胞に対する特異性を有するウイルスカプシドタンパク質
EP4294494A1 (en) 2021-02-22 2023-12-27 Dinaqor AG Loco-regional perfusion of a liver
MX2023009819A (es) 2021-02-22 2024-01-03 Dinaqor Ag Perfusion loco-regional de un ri?on.
KR20230173088A (ko) 2021-02-22 2023-12-26 디나코 아게 정지되지 않은 박동 심장의 국소-영역 관류

Similar Documents

Publication Publication Date Title
JP2023513749A5 (https=)
JP6688812B2 (ja) ファブリー病の遺伝子治療
JP2022525955A (ja) 組換えアデノ随伴ウイルスベクター
Bass-Stringer et al. Adeno-associated virus gene therapy: translational progress and future prospects in the treatment of heart failure
JP2022068187A (ja) 抗体回避性ウイルスベクターのための方法および組成物
CA2827375C (en) Improved aav8 vector with enhanced functional activity and methods of use thereof
JP2022065003A (ja) パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質
US10413598B2 (en) Factor IX gene therapy
JP2022508182A (ja) 組換えウイルスベクター及びそれの産生のための核酸
JP2021519099A (ja) 抗体を回避するウイルスベクター
JP2023524577A (ja) 改変アデノ随伴ウイルス5カプシドおよびその使用
KR20230084542A (ko) 플라코필린 2 유전자 치료 방법 및 조성물
Su et al. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect
KR20250105716A (ko) 간에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법
US11077208B2 (en) Wilson's disease gene therapy
US20220403417A1 (en) Aav-based delivery of thymine kinase 2
WO2026017126A1 (zh) 一种人工设计的新型nrg-1在疾病治疗中的应用
CN115885043A (zh) 用于dwarf开放阅读框的腺相关病毒载体
CN113383082A (zh) 包含α疱疹病毒启动子序列的重组核酸
Park The heart is where AAV9 lies
KR20240114769A (ko) 증진된 발현을 위해 선택된 코작 서열을 포함하는 조성물
CN116019935A (zh) Ago2在制备治疗心衰或糖尿病性心肌病的药物方面的用途及其蛋白、基因、转化体
CN116179605B (zh) 一种重组腺相关病毒载体及其应用
JP7670335B2 (ja) 心不全に応答するエンハンサーポリヌクレオチド、及び前記エンハンサーポリヌクレオチドを含む発現ベクター
CN121759520A (zh) 一种lamp2b的过表达载体及其应用